India's Gland Pharma to produce, supply up to 252 million Sputnik V vaccine doses

Coronavirus chronicle

Reuters
16 March, 2021, 04:00 pm
Last modified: 16 March, 2021, 04:02 pm
A nurse prepares Russia's "Sputnik-V" vaccine for inoculation in a post-registration trials stage at a clinic in Moscow. Photo: Reuters

India's Gland Pharma Ltd said on Tuesday it has entered into an agreement with the Russian Direct Investment Fund to produce and supply up to 252 million doses of the Sputnik V Covid-19 vaccine.

Related Topics

Sputnik Covid-19 Vaccine / Grand Pharma

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.